Exchange Traded Concepts, LLC Legend Biotech Corp Transaction History
Exchange Traded Concepts, LLC
- $4.74 Billion
- Q4 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 3,265 shares of LEGN stock, worth $117,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,265
Previous 3,265
-0.0%
Holding current value
$117,866
Previous $159,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LEGN
# of Institutions
227Shares Held
74.5MCall Options Held
279KPut Options Held
350K-
Price T Rowe Associates Inc Baltimore, MD11.2MShares$403 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$271 Million5.1% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$240 Million7.41% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$207 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.04MShares$182 Million1.16% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $6.04B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...